Literature DB >> 15756498

[Large vessel vasculitis as cause of fever of unknown origin (FUO) or systemic inflammation. Diagnosis using 18-F-fluor-2-deoxy-D-glucose positron emission tomography ((18)F-FDG-PET)].

C C Amberger1, H Dittmann, D Overkamp, K Brechtel, R Bares, I Kötter.   

Abstract

BACKGROUND: Diagnosis and treatment of FUO or systemic inflammation with unknown reason are still a great challenge for the treating physician. We used (18)F-FDG-PET for further diagnostic work in patients in whom a diagnosis could not be established despite intensive diagnostic efforts. METHODS/
RESULTS: We studied nine patients with (18)F-FDG-PET. Two female patients with known Takayasu's arteritis but undefined disease activity, and seven patients with the clinical suspicion of an underlying large vessel vasculitis. The diagnosis of active vasculitis could be confirmed by the PET-results in eight patients. Active vasculitis could be nearly ruled out in one. The diagnoses could be confirmed by follow-up visits.
CONCLUSION: (18)F-FDG-PET is a useful diagnostic tool in patients with unclear systemic inflammation and FUO. Especially when large vessel vasculitis is suspected, further diagnostic work by PET seems to be of benefit. Furthermore, it offers the opportunity to evaluate disease activity and to check which vessels are involved.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15756498     DOI: 10.1007/s00393-005-0639-2

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  27 in total

1.  Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch.

Authors:  D Blockmans; S Stroobants; A Maes; L Mortelmans
Journal:  Am J Med       Date:  2000-02-15       Impact factor: 4.965

2.  Fever of unexplained origin: report on 100 cases.

Authors:  R G PETERSDORF; P B BEESON
Journal:  Medicine (Baltimore)       Date:  1961-02       Impact factor: 1.889

3.  The use of 2-[18F]fluoro-2-deoxy-D-glucose as a potential in vitro agent for labelling human granulocytes for clinical studies by positron emission tomography.

Authors:  S Osman; H J Danpure
Journal:  Int J Rad Appl Instrum B       Date:  1992-02

4.  Augmentations of glucose uptake and glucose transporter-1 in macrophages following thermal injury and sepsis in mice.

Authors:  R L Gamelli; H Liu; L K He; C A Hofmann
Journal:  J Leukoc Biol       Date:  1996-05       Impact factor: 4.962

5.  Fluorine-18-FDG PET and technetium-99m antigranulocyte antibody scintigraphy in chronic osteomyelitis.

Authors:  A Guhlmann; D Brecht-Krauss; G Suger; G Glatting; J Kotzerke; L Kinzl; S N Reske
Journal:  J Nucl Med       Date:  1998-12       Impact factor: 10.057

6.  Fever of unknown origin: prospective comparison of [18F]FDG imaging with a double-head coincidence camera and gallium-67 citrate SPET.

Authors:  J Meller; G Altenvoerde; U Munzel; A Jauho; M Behe; S Gratz; H Luig; W Becker
Journal:  Eur J Nucl Med       Date:  2000-11

Review 7.  A comprehensive evidence-based approach to fever of unknown origin.

Authors:  Ophyr Mourad; Valerie Palda; Allan S Detsky
Journal:  Arch Intern Med       Date:  2003-03-10

Review 8.  18-fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation.

Authors:  Hongming Zhuang; Abass Alavi
Journal:  Semin Nucl Med       Date:  2002-01       Impact factor: 4.446

9.  Fever of unknown origin in the elderly.

Authors:  A L Esposito; R A Gleckman
Journal:  J Am Geriatr Soc       Date:  1978-11       Impact factor: 5.562

10.  Uptake of 11C-methionine in breast cancer studied by PET. An association with the size of S-phase fraction.

Authors:  S Leskinen-Kallio; K Någren; P Lehikoinen; U Ruotsalainen; H Joensuu
Journal:  Br J Cancer       Date:  1991-12       Impact factor: 7.640

View more
  2 in total

1.  [Chronic periaortitis].

Authors:  N Pipitone; C Salvarani; H H Peter
Journal:  Internist (Berl)       Date:  2010-01       Impact factor: 0.743

Review 2.  Febrile conditions in rheumatology.

Authors:  E Tóth; G Speer
Journal:  Clin Rheumatol       Date:  2012-08-26       Impact factor: 2.980

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.